BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34102222)

  • 1. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.
    Menz A; Bauer R; Kluth M; Marie von Bargen C; Gorbokon N; Viehweger F; Lennartz M; Völkl C; Fraune C; Uhlig R; Hube-Magg C; De Wispelaere N; Minner S; Sauter G; Kind S; Simon R; Burandt E; Clauditz T; Lebok P; Jacobsen F; Steurer S; Wilczak W; Krech T; Marx AH; Bernreuther C
    Hum Pathol; 2021 Sep; 115():19-36. PubMed ID: 34102222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
    Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
    Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.
    Menz A; Gorbokon N; Viehweger F; Lennartz M; Hube-Magg C; Hornsteiner L; Kluth M; Völkel C; Luebke AM; Fraune C; Uhlig R; Minner S; Dum D; Höflmayer D; Sauter G; Simon R; Burandt E; Clauditz TS; Lebok P; Jacobsen F; Steurer S; Krech T; Marx AH; Bernreuther C
    Int J Surg Pathol; 2023 Sep; 31(6):927-938. PubMed ID: 35946088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of cytokeratin(CK)7, CK8/18, CK19 and p40 in esophageal squamous cell carcinoma and their correlation with prognosis].
    Yang ZY; Zhang HY; Wang F; Ma YH; Li YY; He HL; Wang C; Li SS
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):834-839. PubMed ID: 30423606
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytokeratin 19 expression in early oral squamous cell carcinoma and their metastasis: Inadequate biomarker for one-step nucleic acid amplification implementation in sentinel lymph node biopsy procedure.
    Noorlag R; van Es RJJ; de Bree R; Willems SM
    Head Neck; 2017 Sep; 39(9):1864-1868. PubMed ID: 28644540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Matrix Metalloproteinase 9 Expression as Supporting Marker to Cytokeratin 19 mRNA in Sentinel Lymph Nodes in Breast Cancer Patients.
    Murawski M; Woźniak M; Duś-Szachniewicz K; Kołodziej P; Rzeszutko M; Ziółkowski P
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 19 expression in intrathoracic neoplasms: First study utilizing cellblocks, evaluating the role of a rarely used cytokeratin for lung cancers.
    Verma V; Rao RN
    Diagn Cytopathol; 2022 Mar; 50(3):105-111. PubMed ID: 34981674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination with CK19 Might Increase the Prognostic Power of Hep Par 1 in Hepatocellular Carcinoma after Curative Resection.
    Jin Y; Liang ZY; Zhou WX; Zhou L
    J Invest Surg; 2018 Oct; 31(5):412-419. PubMed ID: 28758812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver.
    Jain R; Fischer S; Serra S; Chetty R
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):9-15. PubMed ID: 19956064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium.
    Stewart CJ; Crook ML; Lacey J; Louwen K
    Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
    Abouhashem NS; Talaat SM
    Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokeratin-19 (CK19) in the classical subtype of papillary thyroid carcinoma: the experience of one center in the Silesian region.
    Kaliszewski K; Diakowska D; Strutynska-Karpinska M; Rzeszutko M; Grzegrzolka J; Dziegiel P; Wojtczak B; Sutkowski K
    Folia Histochem Cytobiol; 2016; 54(4):193-201. PubMed ID: 28051274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases.
    Masai K; Nakagawa K; Yoshida A; Sakurai H; Watanabe S; Asamura H; Tsuta K
    Lung Cancer; 2014 Dec; 86(3):318-23. PubMed ID: 25453845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection.
    Lee CW; Kuo WL; Yu MC; Chen TC; Tsai CN; Lee WC; Chen MF
    World J Surg Oncol; 2013 Jun; 11(1):136. PubMed ID: 23758804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods.
    Mehrpouya M; Pourhashem Z; Yardehnavi N; Oladnabi M
    J Cell Physiol; 2019 Dec; 234(12):21425-21435. PubMed ID: 31042009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPS1 is a Highly Sensitive Marker for Breast Cancer: A Tissue Microarray Study Evaluating More Than 19,000 Tumors From 152 Different Tumor Entities.
    Lennartz M; Löhr N; Höflmayer D; Dwertmann Rico S; von Bargen C; Kind S; Reiswich V; Viehweger F; Lutz F; Bertram V; Fraune C; Gorbokon N; Weidemann S; Blessin NC; Hube-Magg C; Menz A; Schlichter R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C; Steurer S
    Am J Surg Pathol; 2024 Jun; 48(6):637-651. PubMed ID: 38647255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
    Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
    APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
    Ernst J; Ikenberg K; Apel B; Schumann DM; Huber G; Studer G; Rordorf T; Riesterer O; Rössle M; Korol D; Bredell MG
    Oncotarget; 2016 Nov; 7(46):76151-76158. PubMed ID: 27764819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
    Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
    Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.